Nolato AB Class B (NLTBF)
OTHER OTC:NLTBF
Want to see NLTBF full AI Analyst Report?
NLTBF Stock Chart & Stats
$6.65
$0.27(5.41%)
At close: 4:00 PM EDT
$6.65
$0.27(5.41%)
Day’s Range― - ―
52-Week Range$5.40 - $7.25
Previous CloseN/A
Volume24.00K
Average Volume (3M)0.00
Market Cap
$1.43B
Enterprise Value$13.77B
Total Cash (Recent Filing)$452.00M
Total Debt (Recent Filing)$1.05B
Price to Earnings (P/E)17.8
Beta0.41
Next Earnings
Jul 16, 2026EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend Yield2.38%
Share Statistics
EPS (TTM)2.82
Shares Outstanding241,786,940
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.19
Price to Book (P/B)3.01
Price to Sales (P/S)1.76
P/FCF Ratio0.00
Enterprise Value/Market Cap9.64
Enterprise Value/Revenue1.47
Enterprise Value/Gross Profit8.04
Enterprise Value/Ebitda8.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.33
Revenue Forecast (FY)$1.05B
Bulls Say, Bears Say
Bulls Say
Stable, Healthy MarginsConsistently healthy gross and net margins indicate durable operating profitability driven by product mix and value-added assembly work. Stable margins support recurring earnings, capacity to fund capex and dividends, and provide a buffer against cyclical volume swings over the next 2–6 months.
Low And Improving LeverageA conservative and improving leverage profile reduces financial risk and preserves strategic optionality. Low debt supports capacity for targeted M&A, ongoing CapEx for expansions, and dividend continuity without stressing the balance sheet amid industry cyclicality.
Scale & Growth In Medical SegmentA majority, higher-margin medical business with geographic expansion gives structural demand durability. Regulated medtech customers tend to sign long-term supply agreements, supporting steadier volumes, higher margins, and better ROCE versus commodity industrial segments over the medium term.
Bears Say
Muted Top-line GrowthLimited revenue growth constrains earnings leverage and the company’s ability to scale fixed-cost investments. With revenues largely flat, margin improvements must compensate for weak volume growth, limiting longer-term upside in returns and slowing expansion of absolute cash generation.
Volatile Cash ConversionInconsistent operating cash conversion driven by working-capital swings undermines financial predictability. Volatile FCF can force trade-offs between CapEx, dividends and M&A or require external funding, reducing the practical flexibility that headline profits and low leverage imply.
Input-cost & Start-up Margin PressureExposure to commodity (precious metal) price swings and ramp-up costs for new plants can compress margins unpredictably. Timing of price pass-through is dynamic, so materials volatility plus scaling costs in new regions may weigh on profitability and cash flow into the medium term.
Nolato AB News
NLTBF FAQ
What was Nolato AB Class B’s price range in the past 12 months?
Nolato AB Class B lowest stock price was $5.40 and its highest was $7.25 in the past 12 months.
What is Nolato AB Class B’s market cap?
Nolato AB Class B’s market cap is $1.43B.
When is Nolato AB Class B’s upcoming earnings report date?
Nolato AB Class B’s upcoming earnings report date is Jul 16, 2026 which is in 67 days.
How were Nolato AB Class B’s earnings last quarter?
Nolato AB Class B released its earnings results on May 06, 2026. The company reported $0.073 earnings per share for the quarter, missing the consensus estimate of $0.076 by -$0.004.
Is Nolato AB Class B overvalued?
According to Wall Street analysts Nolato AB Class B’s price is currently Overvalued.
Does Nolato AB Class B pay dividends?
Nolato AB Class B pays a Annually dividend of $0.158 which represents an annual dividend yield of 2.38%. See more information on Nolato AB Class B dividends here
What is Nolato AB Class B’s EPS estimate?
Nolato AB Class B’s EPS estimate is 0.08.
How many shares outstanding does Nolato AB Class B have?
Nolato AB Class B has 241,786,940 shares outstanding.
What happened to Nolato AB Class B’s price movement after its last earnings report?
Nolato AB Class B reported an EPS of $0.073 in its last earnings report, missing expectations of $0.076. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nolato AB Class B?
Currently, no hedge funds are holding shares in NLTBF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nolato AB Class B
Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products for medical technology, pharmaceutical, consumer electronics, telecom, automotive, and other industrial sectors in North America, Sweden, Asia, and other Europe region. The company offers consumables and reusable labware for clinical, chemical, forensic, research, and industrial testing laboratories; manufactures pipette tips, deep-well plates, microtubes, and PCR products; assemblies and post-processing services; and products for primary pharmaceutical packaging, as well as for solids, creams, and ophthalmic and customized production solutions. It designs, develops, and produces advanced components, subsystems, and ready-packaged electronics products, such as laser applications and ceramics, fitness trackers, loudspeaker systems, thermostats, webcams, and vaporiser heating products; automotive products; EMI shielding, thermal interface materials, and silicone sealing and damping solutions; and supplies plastic components and assemblies for food processing equipment, such as coffee machines and blenders. The company was formerly known as Nordiska Latexfabriken i Torekov AB and changed its name to Nolato AB (publ) in 1982. Nolato AB (publ) was incorporated in 1938 and is headquartered in Torekov, Sweden.
NLTBF Company Deck
NLTBF Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive strategic and financial picture for the full year—sales growth, a double-digit increase in operating profit for the year, improved margins, higher EPS, a larger dividend, strong cash generation, improved ROCE and notable sustainability achievements. Near-term Q4-specific headwinds (currency effects, start-up costs, year-end volume weakness and volatile precious metal prices) weighed on quarterly results and will partially carry into Q1 2026, but management characterized these as temporary and actionable (pricing adjustments, ongoing ramp-ups, and planned expansions). Overall, the highlights (annual profitability and margin improvement, medical growth, sustainability milestones and financial strength enabling M&A) outweigh the temporary lowlights.View all NLTBF earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
3.37% Mutual Funds
― Other Institutional Investors
92.86% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---